Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by SPCEO1on Jul 13, 2022 2:18pm
137 Views
Post# 34821500

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Financing - ideal

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Financing - idealI once found something on the maze that is Bloomberg that identified the owners of most of te converts. Unfortunately, I have not been able to find it again but my recollection was there was one large holder. I imagine someone out there has as their business model to acquire converts that do not look like they are going to convert and where the financing is not yet in place to refi them, on the hope the company will figure it out and they will get full price upon the end of the term of the loan. It may be that whoever it was that had that large stake I saw has that as a strategy and then approaches the company saying we have a win/win proposition for you - we will sell our bonds at a small discount to you once you line up the refi. This owner of the convert then gets a nice trading gain as well as a nice chunk of money to reinvest in the next deal. It is probably a really good business model and the returns should be very nice.

palinc2000 wrote:

We dont lnow who the seller(s) were but as you point  point out the default risk is probably cliose to nil so I dont think an informed seller would sell much at a discount greater than the time value of money or close to it
I dont think uou would pick up any large number of Convert at 85$ ...if you could that would be a very good return

 

SPCEO1 wrote: I would like to think the price paid for the repurchased converts is not quite that high but you may be closer to the mark. Since the sellers now know the converts will be redeemed at par, they don't have much incentive to offer a big discount.
 

 

palinc2000 wrote: However the price paid is not 75.50 ...It is probably around 95 $...

palinc2000 wrote: OUPS MY BAD ...I thought Marathon was buying the Convert   Smart move indeed
SORRY SORRY SORRY

palinc2000 wrote: I dont understand your comment...The transfer of ownership from one group to another has no impact on THTX   Marathon "s financing makes the Convert much less risky  of Default and Marathon will make a profit of 6 million but THTX still need to repay that 30 million  
Does Marathon expect the SP to be over the Convert Price and participate in the equity?

Wino115 wrote:

Then roughly buying $30mil principal will only cost around $24mil. Very smart use of proceeds. So there goes well over half the debt, half the interest for only $24 mil.

 

SPCEO1 wrote: Last trade was at $75.50
 

 

Wino115 wrote:

Dies anyone know the current price of the convertible (as of yesterday)? 

 

 

SPCEO1 wrote: If nothing else, it removes the overhang of another ONO from the stock. But will anyone even notice at this point? The stock should jump a lot on this deal because of the removed dilution overhang, the immediate benefit to cash flow over the next 2 years (maybe three years) and the backing of a major healthcare lender of TH's plans for the future. 
 

 

palinc2000 wrote:

Need to see the fine prints     

tee time in 5 minutes will look thid afternoon

 

SPCEO1 wrote: My initial reaction is this is perfect. The opposite of the ONO and indicative of confidence in the future of TH. I will have a closer look later.

 

 


 

 

 

 

 

 

 

 




<< Previous
Bullboard Posts
Next >>